Ethnic Variation in G6PD Deficiency: Epidemiology and Mutation Spectrum in Southern China's Multiethnic Hub, Nanning
Clinical Genetics · 2026
DOI: 10.1111/cge.70144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2026. Verfasst von Jiawei Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Glucosephosphate Dehydrogenase Deficiency, Mutation, Glucosephosphate Dehydrogenase, Ethnicity. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Open Project of NHC Key Laboratory of Thalassemia Medicine, First-class discipline innovation-driven talent program of Guangxi Medical University.
Abstract (Originalsprache)
Glucose‐6‐phosphate dehydrogenase (G6PD) deficiency exhibits high prevalence in malaria‐endemic regions and areas along the historic Maritime Silk Road. This study investigated the burden and genetic architecture of G6PD deficiency in Nanning, the ethnically diverse capital of Guangxi in southern China, where Southeast Asian gene flow has shaped population genetics. We screened 14 403 individuals for G6PD activity at The First Affiliated Hospital of Guangxi Medical University, defining deficiency as activity < 60% of adjusted male median (AMM = 2045 U/L). Among 2513 deficient cases (prevalence: 17.45%), frequency was significantly higher in males (63.75%) vs. females (36.25%; p < 0.001) and Han Chinese (60.92%) vs. Zhuang (39.08%; p = 0.925). Multiplex melting curve analysis (MMCA) of 2513 enzyme‐deficient samples identified pathogenic mutations in 1161 cases, revealing 13 distinct variants. The predominant mutations were: c.1388G>A (39.53%; 459/1161), c.1376G>T (24.81%; 288/1161), and c.95A>G (12.40%; 144/1161). Mutation c.871G>A exhibited male bias ( p < 0.001), while c.95A>G was Zhuang‐enriched ( p < 0.001). Sanger sequencing of MMCA‐negative cases identified two rare pathogenic variants (c.406C>T, c.196T>A). Our findings establish Nanning as a region of exceptionally high G6PD deficiency prevalence and delineate a distinct mutation profile with sex‐ and ethnicity‐linked distributions. These results provide critical insights for designing precision screening programs and public health strategies tailored to this genetically diverse population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, China.
- Guangxi Key Laboratory of Thalassemia Research, Nanning, China.
- NHC Key Laboratory of Thalassemia Medicine, Guangxi Key Laboratory of Thalassemia Research, Nanning, China.
ORCID-Profile: Shengwei Li, Zheng Yang
Förderung
- National Natural Science Foundation of China
- Open Project of NHC Key Laboratory of Thalassemia Medicine
- First-class discipline innovation-driven talent program of Guangxi Medical University
Zitieren
APA
Yang, J., Li, S., Han, Y., Lei, Z., Liao, J., Qiu, Y., & Yang, Z. (2026). Ethnic Variation in G6PD Deficiency: Epidemiology and Mutation Spectrum in Southern China's Multiethnic Hub, Nanning. Clinical Genetics. https://doi.org/10.1111/cge.70144
Vancouver
Yang J, Li S, Han Y, Lei Z, Liao J, Qiu Y, et al. Ethnic Variation in G6PD Deficiency: Epidemiology and Mutation Spectrum in Southern China's Multiethnic Hub, Nanning. Clinical Genetics. 2026. doi:10.1111/cge.70144
BibTeX
@article{Yang2026,
author = {Yang, Jiawei and Li, Shengwei and Han, Yanfeng and Lei, Zixiao and Liao, Jiejun and Qiu, Yuling and Yang, Zheng},
title = {Ethnic Variation in G6PD Deficiency: Epidemiology and Mutation Spectrum in Southern China's Multiethnic Hub, Nanning},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70144}
}
EUVIMED